NVS - NOVARTIS AG
161.01
-4.140 -2.571%
Share volume: 4,260,169
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$165.15
-4.14
-0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | |
|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | |
| Report Date | 04-23-2024 | 07-18-2024 | |
| Assets | |||
| Total Assets | 94.334 B | 97.505 B | |
| Current Assets | 26.447 B | 25.693 B | |
| Inventories | 5.743 B | 5.747 B | |
| Other Current Assets | 2.759 B | 3.031 B | |
| Short Term Investments | 2.759 B | 3.031 B | |
| Total Receivables | 8.251 B | 8.480 B | |
| Current Cash | 9.694 B | 8.435 B | |
| Total Non-current Assets | 67.887 B | 71.812 B | |
| Property Plant Equipment | 9.200 B | 9.254 B | |
| Other Assets | 5.038 B | 5.046 B | |
| Intangible Assets | 26.272 B | 27.775 B | |
| Goodwill | 23.063 B | 25.234 B | |
| Liabilities and shareholders’ equity | |||
| Total Liabilities and shareholders’ equity | 94.334 B | 97.505 B | |
| Total liabilities | 54.659 B | 55.772 B | |
| Total current liabilities | 29.288 B | 27.612 B | |
| Accounts Payable | 4.062 B | 4.146 B | |
| Other liabilities | 4.259 B | 4.312 B | |
| Current long term debt | 8.564 B | 7.764 B | |
| Long term debt | 18.720 B | 21.223 B | |
| Other liabilities | 4.259 B | 4.312 B | |
| Minority interest | 81.000 M | 169.000 M | |
| Total Shareholder equity | 39.675 B | 41.733 B | |
| Common stock | 2.044 B | 2.033 B | |
| Retained earnings | 0.000 | 0.000 |